Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2022
11-1-2022 Air Pollution Effects in Allergies and Asthma, Anil Nanda, University of Texas Southwestern Medical Center, Dallas, TX, Syed Shahzad Mustafa, Rochester Regional Health, Maria Castillo, University of Texas Southwestern Medical Center, Dallas, TX, et al.
11-1-2022 Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee, Autumn C Guyer, Eric Macy, Andrew A White, et al.
11-1-2022 Evaluating Pediatric Penicillin Allergy-The Need to Broaden Indications and Improve Access, S Shahzad Mustafa, Rochester Regional Health and Allison C. Ramsey, Rochester Regional Health
10-11-2022 Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp, Stephanie A. Leonard, Division of Pediatric Allergy / Immunology, University of California San Diego, Rady Children's Hospital, San Diego, CA, United States., Yasushi Ogawa, Medical Affairs, Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States., Paul T. Jedrzejewski, Medical Affairs, Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States., et al.
9-2022 Peanut oral immunotherapy: Reconsidering a one-size-fits-all approach, Lakshmi G. Nair, Rochester Regional Health and Peter Capucilli, Rochester Regional Health
6-9-2022 Contact Dermatitis, Linh-An Tuong, Rochester Regional Health
6-9-2022 Penicillin Allergy and Perioperative Anaphylaxis, Allison Ramsey, Rochester Regional Health
6-2022 Should children with immunoglobulin E–mediated food allergy be screened for eosinophilic esophagitis?, Peter Capucilli, Rochester Regional Health, Allison Ramsey, Rochester Regional Health, Linh-An Tuong, Rochester Regional Health, et al.
5-23-2022 Patient and Clinician Attitudes Towards Telemedicine for Allergy and Immunology, Allison Ramsey, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Jay Portnoy, Section of Allergy, Asthma & Immunology. Children's Mercy Hospital, Kansas City, MO
5-9-2022 Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice, Jay Portnoy, Section of Allergy, Asthma & Immunology. Children's Mercy Hospital, Kansas City, MO, United States., Christina E. Ciaccio, Section of Allergy/Immunology and Pediatric Pulmonology, The University of Chicago, Chicago, IL, United States., Janet Beausoleil, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, United States., et al.
5-2022 Telemedicine in Drug Hypersensitivity, Deva Wells; Katherine L. DeNiro; and Allison Ramsey, Rochester Regional Health
5-1-2022 Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine, S. Shahzad Mustafa, Rochester Regional Health; Sara Patrawala; and Sandhya Khurana
4-12-2022 Practical Approach to Urticaria with Angioedema, Denise Sanchez Tejera, Rochester Regional Health
4-2022 Mise en place de l’immunothérapie orale pour l’allergie à l’arachide en pratique clinique aux États-Unis : huit conseils, S. Shahzad Mustafa, Rochester Regional Health and R Montagne, Aimmune Therapeutics
4-1-2022 Real World Adoption of FDA-approved Peanut Oral Immunotherapy with Palforzia, Sara Patrawala, University of Rochester School of Medicine and Dentistry, Rochester NY., Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.
4-2022 Standardisation de la poudre de graine d’Arachis hypogaea L. (arachide) allégée en graisses (PDAH) pour une immunothérapie orale : test des lots de matériel source, S A. Leonard, University of California San Diego; R Montagne, Aimmune Therapeutics; and S. Shahzad Mustafa, Rochester Regional Health
3-2022 Anaphylaxis knowledge gaps and future research priorities: A consensus report, Timothy E. Dribin, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., David Schnadower, Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Julie Wang, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY., et al.
2-1-2022 Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of β-Lactam Cross-Reactivity, Allison Ramsey, Rochester Regional Health
2-1-2022 The United States Drug Allergy Registry: A Prospective Longitudinal Cohort Study of Patients Tested for Drug Allergies, Kimberly Blumenthal, Allison Ramsey, Rochester Regional Health, S. Shahzad Mustafa, Rochester Regional Health, et al.
1-18-2022 COVID-19: Medication Update, Anja Bottler, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
1-6-2022 COVID, Emil P. Lesho, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Maryrose Laguio-Vila, Rochester Regional Health
Submissions from 2021
12-1-2021 Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose, Linh-An C. Tuong, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, Mary Staicu, Rochester Regional Health, et al.
10-15-2021 Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia, S Shahzad Mustafa, Rochester Regional Health, Saad Jamshed, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, Missouri, United States of America., et al.
8-20-2021 CLL Society's Official Statement on Boosters for Cll (Chronic Lymphocytic Leukemia) Patients, Brian Koffman; Alan Z. Skarbnik; and S. Shahzad Mustafa, Rochester Regional Health
8-10-2021 Drug Allergy Management on the Move, Pascal Demoly, Division of Allergy, Department of Pulmonology, University Hospital of Montpellier, Montpellier, France; IDESP UA11 INSERM-Univ Montpellier, Montpellier, France. and Allison Ramsey, Rochester Regional Health